Matthew D. L. O'COnnell
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Matthew D. L. O'COnnell has a total of 51 co-authors. Here are the top co-authors by number of shared publications:
- Charles David Alexander Wolfe
King’s College London
4 shared publications - David Wyatt
King’s College London
4 shared publications - Iain James Marshall
King’s College London
4 shared publications - Camila Pantoja-Ruiz
Department of Primary Care & Data Science, School of Life Course and Population Sciences (D.T., A.G., C.P.-R., A.B., J.W., I.J.M., C.D.A.W., M.D.L.O.C.), King’s College London, United Kingdom
3 shared publications - Eva S. Emmett
School of Life Course and Population Health Sciences King's College London London UK
3 shared publications - Yanzhong Wang
King’s College London
3 shared publications
Latest Publications
- Open Access
- 11 November 2026
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 28, e89787
Anticipated Effects of Using a Poststroke Patient Portal for Stroke Survivors and Carers: Semistructured Interview Study
Background: Digital technologies are increasingly incorporated into long-term self-management of health conditions, yet their social impact on stroke survivors and carers remains limited. Objective: This study explores how stroke survivors and carers view a prototype web-based application (“portal”) that allows patients to access and contribute up-to-date information about their health and care poststroke and how this might impact their self-management practices. Methods: Through 27 semistructured interviews with 21 stroke survivors and 6 informal carers (performing unpaid care work), we explore the enablers of and barriers to the adoption and use of a portal for stroke survivors. To support discussions, participants were shown images of the portal prototype that displayed various features, including a self-living ability assessment, blood pressure monitoring, and an overview of exemplar personal data. Results: Four themes were identified to articulate the anticipated effects of the portal: (1) portals as potential tools to empower through enabling survivors and carers to access stroke knowledge and enhance self-management; (2) portals as a method that could offer practical support for recovery management, therefore helping survivors manage their recovery; (3) hesitancy about using a portal, particularly regarding tracking recovery through personal data input; and (4) portals as a method to potentially share information to help keep family, friends, and wider support networks informed about their health and its management. Anticipated experiences also varied by social position. Young stroke survivors, for example, said they would value age-appropriate peer connections, while carers anticipated concerns about additional workload. Participants also felt that family members often lacked understanding of stroke impacts, suggesting that portals could help facilitate better communication about invisible and complex disabilities. Conclusions: The anticipated benefits of digital tools for empowering patients need to be weighed against the complexity of people’s health and the additional responsibility digital interventions place on carers to communicate for those with severe disabilities. Our findings suggest that for a portal to be effective, it would need to address not only people’s medical needs but also their social needs, especially their use of informal care. Further research is needed, including with an implemented portal, to understand the use of portals over extended periods.
- 11 November 2026
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 28, e89787
Open AccessAnticipated Effects of Using a Poststroke Patient Portal for Stroke Survivors and Carers: Semistructured Interview Study
Background: Digital technologies are increasingly incorporated into long-term self-management of health conditions, yet their social impact on stroke survivors and carers remains limited. Objective: This study explores how stroke survivors and carers view a prototype web-based application (“portal”) that allows patients to access and contribute up-to-date information about their health and care poststroke and how this might impact their self-management practices. Methods: Through 27 semistructured interviews with 21 stroke survivors and 6 informal carers (performing unpaid care work), we explore the enablers of and barriers to the adoption and use of a portal for stroke survivors. To support discussions, participants were shown images of the portal prototype that displayed various features, including a self-living ability assessment, blood pressure monitoring, and an overview of exemplar personal data. Results: Four themes were identified to articulate the anticipated effects of the portal: (1) portals as potential tools to empower through enabling survivors and carers to access stroke knowledge and enhance self-management; (2) portals as a method that could offer practical support for recovery management, therefore helping survivors manage their recovery; (3) hesitancy about using a portal, particularly regarding tracking recovery through personal data input; and (4) portals as a method to potentially share information to help keep family, friends, and wider support networks informed about their health and its management. Anticipated experiences also varied by social position. Young stroke survivors, for example, said they would value age-appropriate peer connections, while carers anticipated concerns about additional workload. Participants also felt that family members often lacked understanding of stroke impacts, suggesting that portals could help facilitate better communication about invisible and complex disabilities. Conclusions: The anticipated benefits of digital tools for empowering patients need to be weighed against the complexity of people’s health and the additional responsibility digital interventions place on carers to communicate for those with severe disabilities. Our findings suggest that for a portal to be effective, it would need to address not only people’s medical needs but also their social needs, especially their use of informal care. Further research is needed, including with an implemented portal, to understand the use of portals over extended periods.
- Open Access
- 3 November 2026
- Published by JMIR Publications Inc. in JMIR Aging
- Vol. 9, e98665
Temporal Trends in the Prevalence of Frailty in England From 2002 to 2022, With Forecasts to 2040: Longitudinal Secondary Analysis of a National Cohort Study
Background: The increasing life expectancy provides an opportunity for healthy longevity, but frailty is a potential challenge. Existing studies of frailty prevalence in England are largely cross-sectional, use heterogeneous frailty definitions, and rarely break down population-level drivers or project future burden, limiting their use for health and social care planning. Objective: This study aimed to explore temporal trends of frailty prevalence and project scenario-based future prevalence up to 2040 for the community-dwelling population aged 50 years and older in England. Methods: Prevalence of frailty (measured using a frailty index) in the overall sample and subgroups of age, sex, educational level, and marital status from 2002 to 2022 was estimated among the community-dwelling population aged 50 years and older using 10 waves of nationally representative data from the English Longitudinal Study of Ageing (ELSA; n=6226 to 11,218 across waves). The number of individuals with frailty was also derived in each year. Joinpoint regression models were used to explore temporal trends of frailty prevalence. A linear probability regression model was performed using pooled data from 10 waves of the ELSA to explore driving factors and project future prevalence. Decomposition analysis was used to estimate the contribution of individual factors to the change in prevalence. Results: A statistically nonsignificant ( P =.61) increase of 2.3 percentage points from 15.5% (1738/11,218) in 2002 to 17.8% (1108/6226) in 2022 was observed, with the number of individuals with frailty growing from 2,560,122 to 3,791,038 among community-dwelling adults aged 50 years and older in England. Those with advanced age, who were female, had a lower educational level, and/or were single had a consistently higher prevalence of frailty. Opposing contributions netted to this overall change: improvements in sociodemographic conditions and educational attainment and healthier lifestyle behaviors offset 222.5%, 94.9%, and 51.6% of the observed increase, respectively. Under scenario-based projections, prevalence was estimated at 20.5% (95% CI 19.2%-21.9%) in 2040, corresponding to 5,213,689 people with frailty. Conclusions: Despite a modest increase in prevalence among the community-dwelling population aged 50 years and older, the substantial growth in the absolute number of individuals with frailty indicates a likely rise in future care demands. The study contributes a 20-year trend, decomposition, and forecast framework for community-dwelling older adults. Findings support prioritizing broader sociodemographic development alongside educational attainment and healthy lifestyles, with potential policy approaches including income and social protection, housing improvements, access to health care, and prevention. Key limitations include self-reported measures, exclusion of care home residents, and potential influence of unmeasured effects.
- 3 November 2026
- Published by JMIR Publications Inc. in JMIR Aging
- Vol. 9, e98665
Open AccessTemporal Trends in the Prevalence of Frailty in England From 2002 to 2022, With Forecasts to 2040: Longitudinal Secondary Analysis of a National Cohort Study
Background: The increasing life expectancy provides an opportunity for healthy longevity, but frailty is a potential challenge. Existing studies of frailty prevalence in England are largely cross-sectional, use heterogeneous frailty definitions, and rarely break down population-level drivers or project future burden, limiting their use for health and social care planning. Objective: This study aimed to explore temporal trends of frailty prevalence and project scenario-based future prevalence up to 2040 for the community-dwelling population aged 50 years and older in England. Methods: Prevalence of frailty (measured using a frailty index) in the overall sample and subgroups of age, sex, educational level, and marital status from 2002 to 2022 was estimated among the community-dwelling population aged 50 years and older using 10 waves of nationally representative data from the English Longitudinal Study of Ageing (ELSA; n=6226 to 11,218 across waves). The number of individuals with frailty was also derived in each year. Joinpoint regression models were used to explore temporal trends of frailty prevalence. A linear probability regression model was performed using pooled data from 10 waves of the ELSA to explore driving factors and project future prevalence. Decomposition analysis was used to estimate the contribution of individual factors to the change in prevalence. Results: A statistically nonsignificant ( P =.61) increase of 2.3 percentage points from 15.5% (1738/11,218) in 2002 to 17.8% (1108/6226) in 2022 was observed, with the number of individuals with frailty growing from 2,560,122 to 3,791,038 among community-dwelling adults aged 50 years and older in England. Those with advanced age, who were female, had a lower educational level, and/or were single had a consistently higher prevalence of frailty. Opposing contributions netted to this overall change: improvements in sociodemographic conditions and educational attainment and healthier lifestyle behaviors offset 222.5%, 94.9%, and 51.6% of the observed increase, respectively. Under scenario-based projections, prevalence was estimated at 20.5% (95% CI 19.2%-21.9%) in 2040, corresponding to 5,213,689 people with frailty. Conclusions: Despite a modest increase in prevalence among the community-dwelling population aged 50 years and older, the substantial growth in the absolute number of individuals with frailty indicates a likely rise in future care demands. The study contributes a 20-year trend, decomposition, and forecast framework for community-dwelling older adults. Findings support prioritizing broader sociodemographic development alongside educational attainment and healthy lifestyles, with potential policy approaches including income and social protection, housing improvements, access to health care, and prevention. Key limitations include self-reported measures, exclusion of care home residents, and potential influence of unmeasured effects.
- Open Access
- 1 November 2026
- Published by Wolters Kluwer Health in Hypertension
- Vol. 83 (11)
Frailty Index Progression Around Hypertension Diagnosis in 14 Countries
BACKGROUND: Hypertension and frailty frequently coexist in older adults. However, relationships between their trajectories are unclear. This study aims to examine whether frailty progressed differently between individuals with and without hypertension before and after diagnosis. METHODS: Data were drawn from 3 nationally representative cohorts across 14 countries, including 21 418 participants (mean baseline age 63.2±10.2 years) followed for 16 to 18 years. Individuals with hypertension at baseline were excluded. Hypertension was defined by self-reported physician diagnosis and antihypertensive medication use by self-report of taking any medication. Diagnosis timing was based on the first survey wave at which hypertension was reported. Coarsened exact matching matched participants who developed hypertension with those who did not. Piecewise linear mixed models estimated frailty trajectories before and after diagnosis. RESULTS: Among 10 709 participants who developed hypertension (median diagnosis age 70 years), frailty index rescaled to a 0 to 100 scale (0–100) increased by 0.63 points/y (95% CI, 0.57–0.70) before diagnosis and 1.09 points/y (95% CI, 0.97–1.21) after diagnosis. During the 8 years preceding diagnosis, participants who developed hypertension experienced greater increases in frailty index rescaled to a 0 to 100 scale than matched controls without hypertension (difference, 2.69 [95% CI, 2.43–2.95]). The corresponding difference during the 8 years after diagnosis was 1.51 (95% CI, 1.01–2.01). Among individuals with hypertension, antihypertensive medication use was associated with a nonsignificant reduction in frailty progression after diagnosis. Findings remained robust after excluding participants with cardiovascular conditions. CONCLUSIONS: Participants with hypertension experienced faster frailty progression before and after diagnosis. Studies using objective blood pressure measurement are needed to confirm this association.
- 1 November 2026
- Published by Wolters Kluwer Health in Hypertension
- Vol. 83 (11)
Open AccessFrailty Index Progression Around Hypertension Diagnosis in 14 Countries
BACKGROUND: Hypertension and frailty frequently coexist in older adults. However, relationships between their trajectories are unclear. This study aims to examine whether frailty progressed differently between individuals with and without hypertension before and after diagnosis. METHODS: Data were drawn from 3 nationally representative cohorts across 14 countries, including 21 418 participants (mean baseline age 63.2±10.2 years) followed for 16 to 18 years. Individuals with hypertension at baseline were excluded. Hypertension was defined by self-reported physician diagnosis and antihypertensive medication use by self-report of taking any medication. Diagnosis timing was based on the first survey wave at which hypertension was reported. Coarsened exact matching matched participants who developed hypertension with those who did not. Piecewise linear mixed models estimated frailty trajectories before and after diagnosis. RESULTS: Among 10 709 participants who developed hypertension (median diagnosis age 70 years), frailty index rescaled to a 0 to 100 scale (0–100) increased by 0.63 points/y (95% CI, 0.57–0.70) before diagnosis and 1.09 points/y (95% CI, 0.97–1.21) after diagnosis. During the 8 years preceding diagnosis, participants who developed hypertension experienced greater increases in frailty index rescaled to a 0 to 100 scale than matched controls without hypertension (difference, 2.69 [95% CI, 2.43–2.95]). The corresponding difference during the 8 years after diagnosis was 1.51 (95% CI, 1.01–2.01). Among individuals with hypertension, antihypertensive medication use was associated with a nonsignificant reduction in frailty progression after diagnosis. Findings remained robust after excluding participants with cardiovascular conditions. CONCLUSIONS: Participants with hypertension experienced faster frailty progression before and after diagnosis. Studies using objective blood pressure measurement are needed to confirm this association.
- Open Access
- 5 October 2026
- Published by Wiley in Health Expectations
- Vol. 29 (5)
Beyond the Meeting: Patient and Public Involvement Practices and Barriers to Inclusive Participation in Stroke Research
Background: Patient and Public Involvement (PPI) aims to embed patient perspectives in all aspects of health research. In stroke, where diverse impairments affect communication, cognition, and mobility, inclusive PPI is particularly critical yet challenging. Little is known about how stroke PPI is currently practised or what barriers researchers face in supporting the participation of stroke survivors with complex needs. Objectives: To understand how stroke PPI is currently structured and practised, what resources it requires, how research teams support stroke survivors with diverse impairments and what barriers exist to more inclusive practice. Methods: We conducted a national questionnaire with Principal Investigators of NIHR, UKRI and Stroke Association‐funded stroke research projects active between October 2019 and January 2025 (31 responses representing 104/185 eligible projects). Open‐ended questions elicited detailed accounts of PPI practices, resource requirements, adaptations to support diverse participation and barriers to inclusion. Data were analysed using qualitative description and thematic analysis, drawing on concepts of infrastructure to examine how the way PPI is organised shapes participation. Results: Four interconnected themes were identified. Despite considerable variation in scale and sophistication, the group meeting dominated PPI practice, functioning as taken‐for‐granted infrastructure through which involvement happens. Resource constraints, particularly unfunded coordination time and absent specialist communication support, limited what was viable. Researchers consistently reported lacking expertise to support stroke survivors with severe impairments, relying heavily on carers whose involvement sometimes functioned as proxy representation. While participants demonstrated creativity and commitment, PPI groups remained predominantly ‘white, middle class, and [with] minor stroke severity’, with innovation not leading to more inclusive participation. Discussion: Group meetings dominate stroke PPI, but they systematically exclude stroke survivors whose impairments make participating in meetings difficult. Achieving inclusive stroke PPI requires not merely adapting meetings but reimagining participation infrastructure, adequately resourcing diversity work and addressing expertise gaps through multidisciplinary support. Lived Experience or Public Contribution: This research was informed by prior workshops with stroke survivors and carers from two PPI groups, who identified barriers to PPI participation and emphasised the need for methods to support more severely affected stroke survivors. Stroke survivors shaped questionnaire content and helped refine the findings and themes.
- 5 October 2026
- Published by Wiley in Health Expectations
- Vol. 29 (5)
Open AccessBeyond the Meeting: Patient and Public Involvement Practices and Barriers to Inclusive Participation in Stroke Research
Background: Patient and Public Involvement (PPI) aims to embed patient perspectives in all aspects of health research. In stroke, where diverse impairments affect communication, cognition, and mobility, inclusive PPI is particularly critical yet challenging. Little is known about how stroke PPI is currently practised or what barriers researchers face in supporting the participation of stroke survivors with complex needs. Objectives: To understand how stroke PPI is currently structured and practised, what resources it requires, how research teams support stroke survivors with diverse impairments and what barriers exist to more inclusive practice. Methods: We conducted a national questionnaire with Principal Investigators of NIHR, UKRI and Stroke Association‐funded stroke research projects active between October 2019 and January 2025 (31 responses representing 104/185 eligible projects). Open‐ended questions elicited detailed accounts of PPI practices, resource requirements, adaptations to support diverse participation and barriers to inclusion. Data were analysed using qualitative description and thematic analysis, drawing on concepts of infrastructure to examine how the way PPI is organised shapes participation. Results: Four interconnected themes were identified. Despite considerable variation in scale and sophistication, the group meeting dominated PPI practice, functioning as taken‐for‐granted infrastructure through which involvement happens. Resource constraints, particularly unfunded coordination time and absent specialist communication support, limited what was viable. Researchers consistently reported lacking expertise to support stroke survivors with severe impairments, relying heavily on carers whose involvement sometimes functioned as proxy representation. While participants demonstrated creativity and commitment, PPI groups remained predominantly ‘white, middle class, and [with] minor stroke severity’, with innovation not leading to more inclusive participation. Discussion: Group meetings dominate stroke PPI, but they systematically exclude stroke survivors whose impairments make participating in meetings difficult. Achieving inclusive stroke PPI requires not merely adapting meetings but reimagining participation infrastructure, adequately resourcing diversity work and addressing expertise gaps through multidisciplinary support. Lived Experience or Public Contribution: This research was informed by prior workshops with stroke survivors and carers from two PPI groups, who identified barriers to PPI participation and emphasised the need for methods to support more severely affected stroke survivors. Stroke survivors shaped questionnaire content and helped refine the findings and themes.
- Open Access
- 29 January 2026
- Published by Taylor & Francis in Disability and Rehabilitation
- p. 1-12
Patients’ and carers’ perspectives on unrestricted weight-bearing and early mobilisation after hip fracture surgery in Saudi Arabia: a qualitative study
This study explored how patients and carers experienced weight-bearing instructions and mobilisation timing following hip fracture surgery. It also examined their views on unrestricted weight-bearing and early mobilisation and perceived barriers to these practices. Semi-structured interviews were conducted with 25 participants (18 carers, 7 patients) from Saudi Arabia's healthcare systems. The data were analysed using inductive thematic analysis. Participants viewed unrestricted weight-bearing and early mobilisation as important when prescribed by clinicians, reflecting strong trust in professional judgement. However, their experiences showed inconsistency in clinical instructions and how these were understood and implemented. Implementation was shaped by clinical instructions, clarity of communication, perceived safety, and patients' physical capacity and psychological state. Concerns about falls were mostly reported by carers as barriers to mobilisation, although some patients also described fear shaped by past injuries, difficult recoveries, or uncertainty about undiagnosed complications. Carers played a key role in encouraging mobilisation, adapting instructions, and maintaining continuity of care when weight-bearing and mobilisation were challenging for patients. To support adherence to weight-bearing and mobilisation instructions, clinicians should provide timely, consistent prescriptions aligned with evidence-based guidance. Communication must be inclusive to support understanding, confidence, and autonomy among patients and carers.
- 29 January 2026
- Published by Taylor & Francis in Disability and Rehabilitation
- p. 1-12
Open AccessPatients’ and carers’ perspectives on unrestricted weight-bearing and early mobilisation after hip fracture surgery in Saudi Arabia: a qualitative study
This study explored how patients and carers experienced weight-bearing instructions and mobilisation timing following hip fracture surgery. It also examined their views on unrestricted weight-bearing and early mobilisation and perceived barriers to these practices. Semi-structured interviews were conducted with 25 participants (18 carers, 7 patients) from Saudi Arabia's healthcare systems. The data were analysed using inductive thematic analysis. Participants viewed unrestricted weight-bearing and early mobilisation as important when prescribed by clinicians, reflecting strong trust in professional judgement. However, their experiences showed inconsistency in clinical instructions and how these were understood and implemented. Implementation was shaped by clinical instructions, clarity of communication, perceived safety, and patients' physical capacity and psychological state. Concerns about falls were mostly reported by carers as barriers to mobilisation, although some patients also described fear shaped by past injuries, difficult recoveries, or uncertainty about undiagnosed complications. Carers played a key role in encouraging mobilisation, adapting instructions, and maintaining continuity of care when weight-bearing and mobilisation were challenging for patients. To support adherence to weight-bearing and mobilisation instructions, clinicians should provide timely, consistent prescriptions aligned with evidence-based guidance. Communication must be inclusive to support understanding, confidence, and autonomy among patients and carers.
- Open Access
Widening Ethnic Inequalities in Stroke Incidence: A 30-Year Population-Based Analysis of the South London Stroke Register
Aim/background: Ethnic inequalities in stroke incidence are well-established, but long-term trends and the impact of socioeconomic status (SES) remain understudied. We estimated incidence rates by ethnicity over 30-years, and differences by SES, using the South London Stroke Register (1995–2024). Methods: We conducted a population-based study including all residents of a geographically defined area of South London, calculating standardised incidence rates using census-derived denominators and the 2013 European Standard Population. The area-level Index of Multiple Deprivation was the indicator of SES. Poisson regression estimated incidence rate ratios comparing ethnic-minority vs White groups, adjusting for age, sex, and SES, with ethnicity-SES interaction testing and marginal rates derived by subgroup. Results: Among 7,726 people with first-ever stroke, overall standardised incidence decreased 34% between 1995–1999 and 2010–2014 (198;[187.8–208] to 131;[122.4–138.9] per 100,000), then increased 13% in 2020–2024. Black-African and Black-Caribbean populations had higher baseline incidence persisting across all periods. Ethnic inequalities narrowed initially but subsequently widened, with incidence twice as high in Black-African (IRR=2.31;[2.03–2.62]) and Black-Caribbean (IRR=2.00;[1.73–2.31]) groups compared to White groups in 2020–2024. Patterns were consistent across stroke subtypes, with the largest inequalities in primary intracerebral haemorrhage. Ethnic differences in incidence attenuated on SES adjustment but remained significant. Within ethnic groups, most deprived Black-African and Black-Caribbean populations showed highest incidence. Conclusion: Stroke incidence has risen sharply in the past five years, driven by rising incidence rates in Black-African and Black-Caribbean populations, with reduction in the White population. Achieving equity requires ensuring uptake of cardiovascular risk programmes across all socioeconomic and ethnic groups, with earlier risk management for groups who develop stroke 10-12 years younger than the general population.
Open AccessWidening Ethnic Inequalities in Stroke Incidence: A 30-Year Population-Based Analysis of the South London Stroke Register
Aim/background: Ethnic inequalities in stroke incidence are well-established, but long-term trends and the impact of socioeconomic status (SES) remain understudied. We estimated incidence rates by ethnicity over 30-years, and differences by SES, using the South London Stroke Register (1995–2024). Methods: We conducted a population-based study including all residents of a geographically defined area of South London, calculating standardised incidence rates using census-derived denominators and the 2013 European Standard Population. The area-level Index of Multiple Deprivation was the indicator of SES. Poisson regression estimated incidence rate ratios comparing ethnic-minority vs White groups, adjusting for age, sex, and SES, with ethnicity-SES interaction testing and marginal rates derived by subgroup. Results: Among 7,726 people with first-ever stroke, overall standardised incidence decreased 34% between 1995–1999 and 2010–2014 (198;[187.8–208] to 131;[122.4–138.9] per 100,000), then increased 13% in 2020–2024. Black-African and Black-Caribbean populations had higher baseline incidence persisting across all periods. Ethnic inequalities narrowed initially but subsequently widened, with incidence twice as high in Black-African (IRR=2.31;[2.03–2.62]) and Black-Caribbean (IRR=2.00;[1.73–2.31]) groups compared to White groups in 2020–2024. Patterns were consistent across stroke subtypes, with the largest inequalities in primary intracerebral haemorrhage. Ethnic differences in incidence attenuated on SES adjustment but remained significant. Within ethnic groups, most deprived Black-African and Black-Caribbean populations showed highest incidence. Conclusion: Stroke incidence has risen sharply in the past five years, driven by rising incidence rates in Black-African and Black-Caribbean populations, with reduction in the White population. Achieving equity requires ensuring uptake of cardiovascular risk programmes across all socioeconomic and ethnic groups, with earlier risk management for groups who develop stroke 10-12 years younger than the general population.
- Open Access
- 26 December 2025
- Published by SAGE Publications in International Journal of Stroke
- Vol. 21 (6) , 801-814
A systematic review of causal pathways of socioeconomic inequalities in stroke
Background: Socioeconomic status (SES), often measured by education, income, occupation, or area-level deprivation, impacts stroke incidence and outcomes, yet the underlying mechanisms remain unclear. This review synthesizes causal analyses quantifying drivers of these inequalities. Methods: We conducted a systematic review (PROSPERO CRD42024554285) and reported following the PRISMA-2020 guidelines. Observational studies applying causal mediation analysis between SES and stroke risk, disability, or mortality were included from PubMed, Embase, Scopus, and Google Scholar. SES indicators, outcomes, mediators, and decompositions into natural direct effect (NDE) and natural indirect effect (NIE) were extracted. Risk of bias and certainty of evidence were assessed using ROBINS-E and GRADE. A narrative synthesis was undertaken, and findings were illustrated in causal diagrams. Results: Of 12,034 records, 19 studies (15 in high-income countries) were included. Lower SES increased stroke incidence through hypertension (NIE 14–21% of the total effect, moderate certainty), although one study restricted to women reported smaller effects (2–4%). Smoking (6–19.9%, very low certainty). At 3 months post-stroke, the combined outcome of death or disability was higher due to severe strokes (38.5% for ischemic, 57–94% for hemorrhagic, moderate certainty). One study found that hypertension, atrial fibrillation, and smoking together mediated 28.5% of the SES effect on stroke severity (low certainty). Reduced access to thrombolysis and stroke units mediated 2.7% of 3-month disability/mortality (very low certainty), while greater distance to specialized centers explained 48% of inequalities in thrombectomy access (low certainty). Long-term mortality (⩾6 months) was mediated by comorbidities (18%) and healthcare coverage (24–55%), both with low certainty. Conclusions: Hypertension, smoking, and differential stroke severity at presentation are the main pathways through which low SES increases stroke risk and causes worse outcomes. Targeting these may reduce inequalities, though evidence from low-income settings and emerging mediators (e.g. early-life SES, environmental exposures, care quality) is lacking.
- 26 December 2025
- Published by SAGE Publications in International Journal of Stroke
- Vol. 21 (6) , 801-814
Open AccessA systematic review of causal pathways of socioeconomic inequalities in stroke
Background: Socioeconomic status (SES), often measured by education, income, occupation, or area-level deprivation, impacts stroke incidence and outcomes, yet the underlying mechanisms remain unclear. This review synthesizes causal analyses quantifying drivers of these inequalities. Methods: We conducted a systematic review (PROSPERO CRD42024554285) and reported following the PRISMA-2020 guidelines. Observational studies applying causal mediation analysis between SES and stroke risk, disability, or mortality were included from PubMed, Embase, Scopus, and Google Scholar. SES indicators, outcomes, mediators, and decompositions into natural direct effect (NDE) and natural indirect effect (NIE) were extracted. Risk of bias and certainty of evidence were assessed using ROBINS-E and GRADE. A narrative synthesis was undertaken, and findings were illustrated in causal diagrams. Results: Of 12,034 records, 19 studies (15 in high-income countries) were included. Lower SES increased stroke incidence through hypertension (NIE 14–21% of the total effect, moderate certainty), although one study restricted to women reported smaller effects (2–4%). Smoking (6–19.9%, very low certainty). At 3 months post-stroke, the combined outcome of death or disability was higher due to severe strokes (38.5% for ischemic, 57–94% for hemorrhagic, moderate certainty). One study found that hypertension, atrial fibrillation, and smoking together mediated 28.5% of the SES effect on stroke severity (low certainty). Reduced access to thrombolysis and stroke units mediated 2.7% of 3-month disability/mortality (very low certainty), while greater distance to specialized centers explained 48% of inequalities in thrombectomy access (low certainty). Long-term mortality (⩾6 months) was mediated by comorbidities (18%) and healthcare coverage (24–55%), both with low certainty. Conclusions: Hypertension, smoking, and differential stroke severity at presentation are the main pathways through which low SES increases stroke risk and causes worse outcomes. Targeting these may reduce inequalities, though evidence from low-income settings and emerging mediators (e.g. early-life SES, environmental exposures, care quality) is lacking.
- Open Access
- 11 January 2025
- Published by Wiley in Journal of Diabetes Research
- Vol. 2025 (1) , 3307594
The Prevalence and Progression of Microvascular Complications and the Interaction With Ethnicity and Socioeconomic Status in People With Type 2 Diabetes: A Systematic Review and Meta‐Analysis
Introduction: Diabetic nephropathy (DN) and diabetic retinopathy (DR) are serious complications of type 2 diabetes mellitus (T2DM). The reported estimates of prevalence and progression of DN and DR vary widely across studies. We undertook a systematic review and meta‐analysis to determine the extent to which these variations in prevalence and progression of DN and DR may relate to different ethnic groups and socioeconomic status (SES). Methods: We searched the databases Ovid MEDLINE, Global Health, APA Psych Info, Embase, and PubMed for publications from 2005 to September 2023, based on T2DM and DN or DR, which included patient’s ethnicities and SES. Prevalence estimates were summarized by meta‐analysis using random effects models for each microvascular complication, stratified by ethnicity and SES. Data on progression was summarized narratively. Results: Twenty‐seven studies were included. The overall prevalence of DN was 18% (95% CI: 14%, 22%) with no differences noted by ethnic group. Low economic status and low education levels were associated with a 4% increased risk of DN compared to higher levels. Higher prevalence of DR was noted among the Afro‐Caribbeans, 28% (95% CI: 11%, 46%), compared to the White/Caucasian 19% (95% CI: 11%, 27%), and Asian/Indo Asians 25% (95% CI: 9%, 41%). Low‐SES populations have a higher prevalence of DR than high‐SES populations. The average prevalence was 16% (95% CI: 11%, 22%) among the high economic status group, compared to 25% (95% CI:20%, 30%) for the low economic status. Our study showed that Black ethnicity was associated with a higher risk of progression to end‐stage renal disease (ESRD) and diabetic maculopathy compared to other ethnicities. People with high SES had a lower rate of DR progression than those with low SES, odds ratio (OR) (0.63, 95% CI: 53%, 74%). Conclusion: Ethnicity and SES may be associated with differential risk of development and progression of DN and DR. The available evidence was limited by the number of studies and small samples for certain ethnic/socioeconomic groups.
- 11 January 2025
- Published by Wiley in Journal of Diabetes Research
- Vol. 2025 (1) , 3307594
Open AccessThe Prevalence and Progression of Microvascular Complications and the Interaction With Ethnicity and Socioeconomic Status in People With Type 2 Diabetes: A Systematic Review and Meta‐Analysis
Introduction: Diabetic nephropathy (DN) and diabetic retinopathy (DR) are serious complications of type 2 diabetes mellitus (T2DM). The reported estimates of prevalence and progression of DN and DR vary widely across studies. We undertook a systematic review and meta‐analysis to determine the extent to which these variations in prevalence and progression of DN and DR may relate to different ethnic groups and socioeconomic status (SES). Methods: We searched the databases Ovid MEDLINE, Global Health, APA Psych Info, Embase, and PubMed for publications from 2005 to September 2023, based on T2DM and DN or DR, which included patient’s ethnicities and SES. Prevalence estimates were summarized by meta‐analysis using random effects models for each microvascular complication, stratified by ethnicity and SES. Data on progression was summarized narratively. Results: Twenty‐seven studies were included. The overall prevalence of DN was 18% (95% CI: 14%, 22%) with no differences noted by ethnic group. Low economic status and low education levels were associated with a 4% increased risk of DN compared to higher levels. Higher prevalence of DR was noted among the Afro‐Caribbeans, 28% (95% CI: 11%, 46%), compared to the White/Caucasian 19% (95% CI: 11%, 27%), and Asian/Indo Asians 25% (95% CI: 9%, 41%). Low‐SES populations have a higher prevalence of DR than high‐SES populations. The average prevalence was 16% (95% CI: 11%, 22%) among the high economic status group, compared to 25% (95% CI:20%, 30%) for the low economic status. Our study showed that Black ethnicity was associated with a higher risk of progression to end‐stage renal disease (ESRD) and diabetic maculopathy compared to other ethnicities. People with high SES had a lower rate of DR progression than those with low SES, odds ratio (OR) (0.63, 95% CI: 53%, 74%). Conclusion: Ethnicity and SES may be associated with differential risk of development and progression of DN and DR. The available evidence was limited by the number of studies and small samples for certain ethnic/socioeconomic groups.